ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
132 hedge funds and large institutions have $755M invested in Achillion Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 32 increasing their positions, 43 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
26% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 43
62% less call options, than puts
Call options by funds: $30M | Put options by funds: $78.5M
Holders
132
Holding in Top 10
1
Calls
$30M
Puts
$78.5M
Top Buyers
| 1 | +$45.3M | |
| 2 | +$45.3M | |
| 3 | +$33.1M | |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$19.1M |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$17.2M |
Top Sellers
| 1 | -$39.5M | |
| 2 | -$18.9M | |
| 3 | -$16.5M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$12.5M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$11.1M |